DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global innovator in kidney care, advanced scientific exchange with 14 new data presentations about the role innovation plays ...

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX) today announced enrollment of the first patient in a U.S. clinical trial for VIVIA, an investigational home hemodialysis (HD) ...

Gift Article 10 Remaining As a subscriber, you have 10 articles to gift each month. Gifting allows recipients to access the article for free. Baxter International Inc., one of the biggest makers of ...

DEERFIELD - Baxter International Inc., an innovator in kidney care, gave 14 data presentations at the Kidney Week 2022 conference last weekend in Orlando, Florida. The company highlighted the role ...

Baxter put forward clinical data showing that its expanded hemodialysis approach, which aims to filter out a greater range of harmful molecules from the bloodstream, was able to help reduce the number ...

Gift Article 10 Remaining As a subscriber, you have 10 articles to gift each month. Gifting allows recipients to access the article for free. Baxter International Inc. will begin accepting more new ...

Baxter generates most of its revenue in these segments from at-home patients using its peritoneal dialysis, or PD, tools. However, it also sells hemodialysis products to dialysis clinics and ...

Baxter has settled on a name for its $4.5 billion kidney care division, which is slated to strike out on its own as an independent portfolio of dialysis machines, acute renal therapies and services.